Efficacy and safety of escitalopram in treatment of severe depression in Chinese population
Crossref DOI link: https://doi.org/10.1007/s11011-017-9992-5
Published Online: 2017-03-15
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Si, Tianmei
Wang, Gang
Yang, Fude
Fang, Yiru
Fang, Maosheng
Li, Jijun
Dong, Jicheng
Shen, Xinhua
Zhuo, Jianmin
Rui, Qing
Wang, Jinan
Cuili, Hu
Funding for this research was provided by:
Xi'an Janssen Pharmaceutical Ltd. Beijing, China
License valid from 2017-03-15